The following is a summary of “Twice against thrice-weekly hemodialysis (TATH): a multicenter nonrandomized trial,” published in the April 2025 issue of BMC Nephrology by Aoun et al. The ideal frequency for maintenance hemodialysis is still unclear. Twice-weekly sessions remain common in many regions. The study assessed survival and potential risks over a 2-year period. […]
The post Comparing Twice and Thrice Weekly Hemodialysis Across Multiple Centers first appeared on Physician’s Weekly.
